From: Prediction of Sjögren’s disease diagnosis using matched electronic dental-health record data
Variable | Non-SD Control (n = 371) | SD Case (n = 129) | Total (N = 500) | p-value |
---|---|---|---|---|
Age, mean (std. dev.) | 56.2 (16.5) | 55.3 (15.8) | 56.0 (16.3) | 0.231 |
Gender, n (%) | 0.996 | |||
Female | 346 (93.3) | 118 (91.5) | 464 (92.8) | |
Male | 23 (6.2) | 11 (8.5) | 34 (6.8) | |
Unknown | 2 (0.5) | 0 (0) | 2 (0.4) | |
Race, n (%) | 0.794 | |||
Asian/Pacific Islander | 3 (0.8) | 2 (1.6) | 5 (1.0) | |
Black or African American | 70 (18.9) | 27 (20.9) | 97 (19.4) | |
Multiracial | 3 (0.8) | 1 (0.8) | 4 (0.8) | |
Other/Unknown | 6 (1.6) | 1 (0.8) | 7 (1.4) | |
White | 288 (77.6) | 98 (76.0) | 386 (77.2) | |
American Indian or Alaska Native | 1 (0.3) | 0 (0) | 1 (0.2) | |
Drug Class, n (%) | ||||
Antimalarials | 4 (1.1) | 18 (14.0) | 22 (4.4) | 7.00E-06 |
Glucocorticosteroids | 59 (15.9) | 47 (36.4) | 106 (21.2) | 1.52E-07 |
Nonsteroidal Anti-inflammatory Agents (NSAIDs) | 88 (23.7) | 49 (38.0) | 137 (27.4) | 0.001 |
Throat Products - Misc. | 3 (0.8) | 14 (10.9) | 17 (3.4) | 2.49E-05 |
Diagnosis Category, n (%) | ||||
Depressive disorder | 56 (15.1) | 42 (32.6) | 98 (19.6) | 1.77E-05 |
Diabetes | 60 (16.2) | 21 (16.3) | 81 (16.2) | 0.943 |
Myalgia and myositis/Fibromyalgia | 24 (6.5) | 36 (27.9) | 60 (12.0) | 4.13E-08 |
Pain in joints | 73 (19.7) | 58 (45.0) | 131 (26.2) | 3.10E-07 |
Systemic lupus erythematosus | 5 (1.3) | 21 (16.3) | 26 (5.2) | 1.35E-06 |
Tear Film Insufficiency | 5 (1.3) | 21 (16.3) | 26 (5.2) | 3.66E-06 |
Dental Procedure Category, n (%) | ||||
Diagnostic | 323 (87.1) | 107 (82.9) | 430 (86.0) | 0.239 |
Surgery | 68 (18.3) | 45 (34.9) | 113 (22.6) | 8.40E-05 |
Laboratory Test: Rheumatoid Factor, n (%) | 9 (2.4) | 18 (14.0) | 27 (5.4) | 1.18E-05 |
Dry Mouth, n (%) | 10 (2.7) | 38 (29.5) | 48 (9.6) | 1.70E-10 |
Dry Eyes, n (%) | 0 (0) | 12 (9.3) | 12 (2.4) | 1.99e-08 |